Obstetrics and Clinical Genetics
The Obstetrics and Clinical Genetics group focuses on the impact of common pregnancy disorders, especially hypertensive pregnancy disorders, and rare diseases on maternal and child health.
Background & Aims:
The impact of pregnancy disorders is not limited to obstetric and pediatric domains, as they are also associated with increased risk of cardiometabolic disorders in later life of the mother and the child. Current research of the group aims at improving the identification of at-risk mothers in order to prevent the potential negative health effects of these disorders on both mothers and children in the short and long term.
The Obstetrics and Clinical Genetics research group is a team of 7 senior researchers and 3 researchers based in Tampere, Helsinki and Oulu, with expertise from the fields of obstetrics and gynaecology, clinical genetics, nutrigenetics, bioinformatics, evolutionary biology and perinatology. The research group is located at the Faculty of Medicine and Health Technology, Department of Obstetrics and Gynecology.
– Lifestyle intervention on cardiovascular diseases prevention.
– Pathomechanism and genetic risk factors for pre-eclampsia and hypertensive pregnancy disorders
– Maternal and neonatal outcomes after infertility treatments
– Prediction models for metabolic syndrome of pregnancy (MSOP) and pre-eclampsia.
– Pregnancy outcomes in women with rare diseases and gut microbiota metabolism in pregnancy.
The Obstetrics and Clinical Genetics group collaborates with various national universities and research groups and projects (FinnGen, FINNPEC, Current Care Guidelines). The group is involved in Nordic collaborations such as the InterPregGen Consortium and the establishment of a Nordic Center for Women’s and Reproductive Health. At European level the group participates in a regional collaboration for the early prediction and prevention of Metabolic Syndrome Of Pregnancy and pre-eclampsia (MSOP-PRE). Globally, the group collaborates with the Global Pregnancy Collaboration and the iPlacenta, a doctoral-level European training network.
Learn more about the Obstetrics and Clinical Genetics Research Group.
Group leader Hannele Laivuori, MD, PhD, Professor of Obstetrics and Gynecology
Tampere University, Faculty of Medicine and Health Technology
+358 50 4154871
Finn-Medi 1, 3-113